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Abstract 
Introduction:  Neural respiratory drive, quantified by the parasternal intercostal 
muscle electromyogram (EMGpara), provides a sensitive measure of respiratory 
system load-capacity balance.  Reference values for EMGpara-based measures are 
lacking and the influence of individual anthropometric characteristics is not known.  
EMGpara is conventionally expressed as a percentage of that obtained during a 
maximal inspiratory effort (EMGpara%max), leading to difficulty in applying the 
technique in subjects unable to reliably perform such manoeuvres.   
Aims:  To measure EMGpara in a large, unselected cohort of healthy adult subjects in 
order to evaluate relevant technical and anthropometric factors. 
Methods:  Surface second intercostal space EMGpara was measured during resting 
breathing and maximal inspiratory efforts in 63 healthy adult subjects, median (IQR) 
age 31.0 (25.0 – 47.0) years, 28 males.  Detailed anthropometry, spirometry and 
respiratory muscle strength were also recorded.   
Results:  Median (IQR EMGpara was 4.95 (3.35 – 6.93)µV, EMGpara%max 4.95 (3.39 
– 8.65)% and neural respiratory drive index (NRDI, the product of EMGpara%max 
and respiratory rate) was 73.62 (46.41 – 143.92) arbitrary units.  EMGpara increased 
significantly to 6.28 (4.26 – 9.93)µV (p<0.001) with a mouthpiece, noseclip and 
pneumotachograph in situ.  Median (IQR) EMGpara was higher in female subjects 
(5.79 (4.42 – 7.98)µV versus 3.56 (2.81 – 5.35)µV, p=0.003); after controlling for sex 
neither EMGpara, EMGpara%max or NRDI were significantly related to 
anthropometrics, age or respiratory muscle strength.   In subjects undergoing repeat 
measurements within the same testing session (n=48) or on a separate occasion 
(n=19) similar repeatability was observed for both EMGpara and EMGpara%max. 
Conclusions:  EMGpara is higher in female subjects than males, without influence of 
other anthropometric characteristics.  Reference values are provided for EMGpara-
derived measures.  Expressing EMGpara as a percentage of maximum confers no 
advantage with respect to measurement repeatability, expanding the potential 
application of the technique.  Raw EMGpara is a useful marker of respiratory system 
load-capacity balance. 
 
 
 
 
 
  
 
Introduction 
Measurement of neural respiratory drive (NRD), the output of brainstem respiratory 
centres, provides a marker that reflects the balance between the physiological load 
on the respiratory system and the capacity of the respiratory muscles.  Such a 
measure may provide a useful composite index of overall respiratory system 
derangement in the presence of disease, or during physiological studies.  NRD 
cannot be quantified at source in human subjects; instead, the neural input to 
selected important respiratory muscles in the form of the electromyogram (EMG) 
can be used as an index of NRD.  As the primary muscle of inspiration, the diaphragm 
remains the best option for measurement of NRD and such measures reflect lung 
disease severity in chronic obstructive pulmonary disease and cystic fibrosis (Jolley et 
al., 2009; Reilly et al., 2011).  Obtaining accurate, uncontaminated EMG signals from 
the diaphragm however requires the passage of an oesophageal catheter, rendering 
the technique unsuitable for widespread use. 
 
The parasternal intercostal muscles are obligate muscles of inspiration, recruited in 
tandem with the diaphragm and displaying similar patterns of activity.  Although 
early research in both animal and human subjects used needle EMG techniques (De 
Troyer & Sampson M.G., 1982; De Troyer, 1984; Decramer & De Troyer, 1984), the 
anatomical location of the parasternal intercostal muscles and the lack of active 
overlying musculature allows their electrical activity to be assessed using surface 
electrodes.  The potential utility of parasternal intercostal muscle EMG (EMGpara) 
measurements as a marker of NRD has been established in both clinical and 
laboratory settings, in health and disease.  Relationships between EMGpara and 
disease severity in obstructive lung diseases have been demonstrated (Maarsingh et 
al., 2002; Reilly et al., 2011; Steier et al., 2011; Reilly et al., 2012), along with 
increases in EMGpara in response to externally-imposed respiratory load in healthy 
subjects (Reilly et al., 2013).  Differences between healthy individuals and those with 
lung disease have also been demonstrated (Steier et al., 2009; Murphy et al., 2011; 
Reilly et al., 2011; Steier et al., 2011), via comparison to small groups of matched 
individuals. 
 As with other EMG measurements, EMGpara has been expressed as a percentage of 
the signal obtained during a maximal inspiratory effort (EMGpara%max) in order to 
minimise inter-individual and inter-occasion variability arising from differences in 
muscle-electrode distance and electrode placement.  Obtaining reliable and 
reproducible maximal inspiratory efforts may not however be possible in all subject 
groups, such as young children or individuals with reduced levels of consciousness.  
Reproducibility of EMGpara%max measurements has been demonstrated (Murphy 
et al., 2011; Reilly et al., 2011), but these studies have mainly been undertaken in 
small groups of healthy individuals experienced in respiratory manoeuvres. It is not 
known whether naïve subjects are as able to reliably perform such maximal 
respiratory efforts reproducibly. 
 
Robust reference data for EMGpara in large groups of healthy adult subjects, such as 
those available for EMGdi (Jolley et al., 2009), are not available and no previous 
studies have, to our knowledge, investigated the influence of anthropometric 
characteristics on the EMGpara signal.  Such data would facilitate standardised 
interpretation of EMGpara measurements made in both research and clinical 
populations. 
 
The aims of the current study were therefore: 
 To measure EMGpara in a large, unselected cohort of healthy adults 
 To determine anthropometric factors influencing EMGpara, thereby deriving 
reference data for EMGpara 
 To evaluate reproducibility of the raw (EMGpara) and normalised 
(EMGpara%max) signals. 
 
 
 
  
Methods 
Subjects 
The study conformed to the requirements of the Declaration of Helsinki.  Ethical 
approval was obtained from the Biomedical Sciences, Dentistry, Medicine and 
Natural Mathematical Sciences Research Ethics Subcommittee of King’s College 
London (reference number BDM/13/14-87).  All participants provided informed 
written consent prior to commencing the study. 
 
Participants were recruited via local intranet advertisements, posters within the 
hospital, and via word of mouth.  Subjects were eligible for inclusion if they were 
aged over 18 years of age, a non-smoker and had no history of respiratory, cardiac or 
neurological disease.  Any subjects demonstrating cough or coryzal symptoms at the 
time of testing were excluded.  Subjects with abnormal spirometry were excluded 
(further details below).  Testing was conducted in a climate-controlled room 
maintained at 23 degrees centigrade.  Measurements were performed at least two 
hours following food or drink consumption. 
 
Spirometry 
All participants performed spirometry with a hand-held electronic spirometer 
incorporating a Fleisch-type pneumotachograph meeting international guidelines 
(In2ative, Vitalograph Ltd., Buckingham, England).  Spirometry was performed in 
accordance with ATS/ERS criteria (Miller et al., 2005); efforts were continued until 
the subject had produced three technically-acceptable forced vital capacity 
manoeuvres from which the highest two values for both FEV1 and FVC were within 
0.15l.  The highest values for both FEV1 and FVC were reported.  Prior to each testing 
session, the accuracy of the spirometer was verified using a 3 litre gas syringe.  All 
values were corrected to BTPS conditions and expressed as standardised residuals 
(“z scores”) relative to the predicted values for age, height, sex and ethnicity 
described by the Global Lung Initiative (Quanjer et al., 2012).  Any subjects 
demonstrating an abnormal FVC or FEV1 (greater than 1.96 z-scores below the 
predicted value) were excluded from further participation. 
 
Anthropometrics and body composition analysis 
Subjects were asked to remove footwear and any heavy clothing.  Height was 
measured using a wall-mounted stadiometer (Harpenden, Holtain Ltd, Crymych, UK) 
with a resolution of 1mm and a range of 600-2100mm, validated daily with a 
certified one-metre bar.  Weight was measured using an electronic scale (HR Person 
Scale, Marsden Ltd, Henley-on-Thames, UK) with a resolution of 50g and maximum 
capacity of 300kg, validated daily with calibrated weights.  Body mass index was 
calculated by dividing the subject’s weight by the square of their height in metres.   
 
Waist and hip circumference were measured in centimetres using a non-extensible 
measuring tape placed around the narrowest part of the abdomen (or, if unclear, the 
midpoint between the inferior border of the tenth rib and the iliac crest) and around 
the level of the greater trochanter respectively.  Waist-hip ratio was calculated as a 
measure of central obesity.  Neck circumference was measured in centimetres at the 
level of the laryngeal prominence with the tape orientated perpendicular to the long 
axis of the neck, and was used as a measure of upper body adiposity. 
 
Bioelectrical impedance was used to calculate body fat percentage using a Quadscan 
4000 (Bodystat Ltd, Douglas, Isle of Man) in accordance with the manufacturer’s 
guidelines.  The subject lay supine for five minutes prior to measurement to allow 
body water redistribution to occur.  After skin preparation using an alcohol swab, 
two electrodes were placed on the dorsum of the right foot over the 2nd 
metatarsophalangeal joint and between the lateral and medial malleoli of the ankle, 
and two over the dorsum of the right hand at the level of the 2nd 
metacarpophalangeal joint and the midpoint of the wrist orientated transversely 
across the joints.  Fat and lean mass and fat percentage were recorded.  
 
Electromyography 
Skin was prepared in accordance with international guidelines for EMG recording 
(Hermans et al., 2000).  Initially the skin was scrubbed with an abrasive gel (Nuprep, 
Weaver and Company, Aurora, USA) to remove dead skin cells and excessive sebum 
in order to minimise electrode-skin impedance.  Any remaining gel and sebum was 
then removed with an alcohol-impregnated wipe before self-adhesive silver-silver-
chloride electrodes were applied (Kendall Arbo, Tyco Healthcare, Neustadt/Donau, 
Germany).  Electrodes were positioned in the second intercostal space bilaterally, 
3cm lateral to the sternum, with a reference electrode placed on the clavicle or the 
acromion process of the scapula. 
 
Signals were amplified (gain 1,000) and band-pass filtered between 10 and 2,000Hz, 
with an additional adaptive mains filter to minimise mains frequency interference, 
using a CED 1902 biomedical amplifier (Cambridge Electronic Design, Cambridge, 
UK).  EMG signals were acquired (PowerLab 8/35, ADInstruments, Sydney, Australia) 
and displayed on a laptop computer running LabChart software (Version 7.2, 
ADInstruments Pty, Colorado Springs, USA) with analogue to digital sampling at 
10kHz.  Both amplifier and analogue-to-digital convertor were earthed to suitable 
points in the laboratory.  Additional digital post-acquisition band-pass filtering 
between 20-1,000Hz was applied via the LabChart software to isolate the 
frequencies of interest.  Data were displayed as both raw EMG and as a root mean 
square (RMS) trace, using a moving average window of 50ms (Ives & Wigglesworth, 
2003).   
 
EMGpara was recorded during tidal breathing.  Subjects were seated upright in a 
chair with back supported, arms placed on armrests and feet flat on the floor to 
minimise trunk postural activity.  Subjects were instructed to remain still and not to 
speak throughout the recording period.  EMGpara was also recorded during maximal 
inspiratory efforts, as described by other authors (Jolley et al., 2009; Reilly et al., 
2011; Steier et al., 2011), in order to allow normalisation of the resting signal to 
maximal EMGpara activity.  EMGpara was recorded during sniff nasal inspiratory 
pressure (SNIP) and maximal inspiratory pressure (PImax) manoeuvres, during 
inspiration to total lung capacity (TLC) and during a single fifteen-second maximum 
voluntary ventilation (MVV).  The highest EMGpara recorded during each maximal 
manoeuvre was identified and reported. An example of recorded EMGpara data is 
shown in Figure 1.
 
Figure 1:  Example EMGpara recordings during tidal breathing (1a), inspiration to total lung capacity (1b) and maximal sniff manoeuvre (1c) 
from a 32 year-old female subject, showing raw EMGpara trace (“EMGpara”), root mean square (“EMGparaRMS”) and respiratory flow (1a 
only, inspiration positive).
  
 
Following visual inspection of the traces to ensure absence of artifact from external 
electromagnetic interference or cross-talk from other musculature, inspiratory 
EMGpara activity, occurring between QRS complexes, was highlighted and the peak 
RMS EMGpara calculated.  The mean peak RMS EMGpara per breath was calculated 
over the final minute of each recording period.  EMGpara was expressed both as a 
raw RMS value in microvolts (µV) termed“EMGpara” and as a percentage of the 
highest RMS EMGpara value recorded during the maximal inspiratory efforts 
(“EMGpara%max”).  The neural respiratory drive index (NRDI, expressed in 
%.breaths/min (%.BPM)) was also calculated as the product of EMGpara%max and 
respiratory rate (Murphy et al., 2011).  
 
Measurement of respiratory flow, volume and airway pressure 
In order to facilitate identification of respiratory phase, respiratory flow was 
measured using a pneumotachograph (4500 series, range 0-160l/min, Hans Rudolph 
Inc, Kansas City, USA) attached to a flanged mouthpiece.  Subjects wore a noseclip.  
The pressure drop across the pneumotachograph was measured using a differential 
pressure transducer (Spirometer, AD Instruments, Castle Hill, Australia).  Airway 
pressure was measured during manoeuvres for respiratory muscle strength 
assessment using a second differential pressure transducer (MP45, Validyne, 
Northridge, USA) and associated carrier amplifier (CD280, Validyne, Northridge, 
USA).  The system had a combined frequency response of 42Hz, in line with 
international recommendations (American Thoracic Society & European Respiratory 
Society, 2002).  The flow and airway pressure signals were acquired by the data 
acquisition system with 100Hz analogue to digital sampling and displayed alongside 
the EMGpara on the LabChart software.  Volume was derived via digital integration 
of the flow signal. 
 
 
 
Measurement of respiratory muscle strength 
Inspiratory muscle strength was measured in accordance with ATS/ERS criteria 
(American Thoracic Society & European Respiratory Society, 2002).  Sniff nasal 
inspiratory pressure (SNIP) was measured using a bung placed in the most patent 
nostril and attached to the differential pressure transducer via a non-compressible 
polyethylene catheter.  Subjects were asked to perform a series of short, sharp 
maximal sniffs, repeated until three sniffs with peak pressures of within 5% were 
achieved with the highest pressure reported.  Quality assurance criteria as per Uldry 
and Fitting were applied (Uldry & Fitting, 1995). 
 
Maximal inspiratory pressure (PImax) was assessed by asking the subject to perform 
a maximal inspiratory effort from functional residual capacity against a closed valve.  
A small leak (2mm internal diameter) was incorporated into the apparatus to 
prevent recruitment of orofacial musculature and ensure an open glottis.  PImax was 
calculated as the highest mean pressure over one second (American Thoracic Society 
& European Respiratory Society, 2002).  The highest value of three reproducible 
efforts was reported. 
 
 
 
Protocol 
Subjects attended the laboratory on a single occasion, with a subset returning for 
repeat measurements to investigate inter-occasion reproducibility of the technique.  
On initial attendance, subjects undertook anthropometric and spirometric 
measurements, followed by assessment of bioelectrical impedance.  Electrodes were 
then applied and EMGpara recorded.  Adopting this order of testing ensured the 
subjects had sufficient rest and there was no influence of the maximum efforts 
required for spirometry on the EMGpara data. 
 
EMGpara was recorded during five minutes of resting breathing without a 
mouthpiece, followed by a further five minutes with the mouthpiece, 
pneumotachograph and noseclip in situ.  Maximal respiratory manoeuvres were 
then performed in the following order: inspiration to TLC, SNIP, PImax and MVV.  If 
subjects consented, electrodes were removed, skin re-prepared and all EMGpara 
measurements repeated.  In the subjects able to return, testing was repeated at 
least seven days after the initial testing occasion at which point all EMGpara 
measurements were performed. 
 
Statistical analysis 
Statistical analysis was undertaken using SPSS Version 22 (IBM, USA).  Normality of 
data distribution was assessed using D’Agostino Pearson testing.  Inspection of the 
data demonstrated multiple variables to have a non-normal distribution and non-
parametric statistical testing was therefore used throughout, with data expressed as 
median (IQR).  Inter-occasion agreement was assessed using Wilcoxon’s matched 
pairs tests and Bland-Altman plots (Bland & Altman, 1986).  Relationships between 
variables were assessed using Spearman’s correlation coefficients.  Differences 
between groups were assessed using Mann-Whitney U test and within-subject 
differences using the related samples Wilcoxon signed rank test.  Significance was 
accepted at p<0.05. 
 
The study was conducted using a convenience sample and no a priori power 
calculation was undertaken.  The acquired sample size was sufficient to accurately 
detect a correlation coefficient of 0.4 with 90% power at the 5% level. 
 
 
 
Results 
A total of 79 subjects were recruited, from whom 63 acceptable data sets were 
obtained.  Of the 16 participants excluded, 14 were due to abnormal findings on 
spirometry and two due to excessive ambient electrical interference on the EMG 
recording.  Data regarding intra-occasion reproducibility were available in 48 
subjects, with inter-occasion reproducibility data obtained from 19 participants.  
Subject characteristics are shown in Table 1. 
  All subjects (n=63) 
Intra-occasion measurements 
available (n=48) 
Inter-occasion measurements 
available (n=19) 
Age (years) 
31.0 
(25.0 – 47.0) 
31.0 
(22.3 – 47.0) 
27.0 
(24.0 – 43.0) 
Sex (M : F) 28 : 35 23 : 25 9 : 10 
Height (cm) 
168.0 
(164.0 – 176.0) 
168.8 
(163.3 – 176.0) 
170.0 
(162.0 – 176.0) 
Weight (kg) 
66.5 
(58.3 – 79.0) 
69.9 
(60.4 – 83.7) 
69.5 
(60.0 – 76.0) 
Body mass index (kg.m-2) 
23.9 
(20.9 – 25.7) 
25.0 
(21.3 – 26.1) 
24.5 
(20.8 – 25.5) 
Waist-hip ratio 
0.81 
(0.76 – 0.87) 
0.83 
(0.77 – 0.88) 
0.81 
(0.74 – 0.88) 
Neck circumference (cm) 
34.5 
(31.5 – 38.5) 
36.0 
(32.0 – 39.0) 
34.0 
(31.0 – 38.0) 
Fat-free mass (%) 
76.1 
(70.7 – 80.0) 
76.1 
(69.0 – 79.8) 
76.1 
(67.7 – 82.2) 
FEV1 (z score) 
-0.3 
(-0.7 – 0.1) 
-0.27 
(-0.84 – 0.08) 
-0.30 
(-0.65 – 0.14) 
FVC (z score) 
-0.1 
(-0.6 – 0.5) 
-0.14 
(-0.53 – 0.57) 
-0.04 
(-0.34 – 0.65) 
FEV1/FVC ratio (z score) 
-0.4 
(-1.0 – 0.2) 
-0.43 
(-0.98 – 0.15) 
-0.33 
(-1.02 – 0.18) 
Ethnicity (n (%)) 
White:  53 (84.1%) 
Black:  3 (4.7%) 
Asian:  7 (11.1%) 
White:  39 (81.2%) 
Black:  3 (6.3%) 
Asian:  6 (12.5%) 
White:  17 (89.4%) 
Asian:  2 (10.6%) 
Table 1  Demographic and anthropometric characteristics of study participants.  Data are expressed as median (IQR).  
Relationships with anthropometrics, spirometry and respiratory muscle strength and 
influence of sex 
For the cohort overall, median (IQR) EMGpara was 4.95 (3.35 – 6.93)µV, 
EMGpara%max was 4.95 (3.39 – 8.65)% and NRDI was 73.62 (46.41 – 143.92)%.BPM.  
Significant inverse relationships were observed between both EMGpara and 
EMGpara%max and height, weight, BMI and respiratory muscle strength (Table 2), 
with the exception of EMGpara and SNIP.  Inverse relationships were also seen 
between both EMGpara and EMGpara%max and FEV1 and FVC when expressed in 
litres, although these relationships were not retained when spirometric values were 
expressed relative to predicted.  Age was not related to either EMGpara (r=0.099, 
p=0.44) or EMGpara%max (r=-0.119, p=0.354). 
  
  
EMGpara EMGpara%max 
 Spearman’s 
rho 
p value 
Spearman’s 
rho 
p value 
Height -0.459 <0.001 -0.627 <0.001 
Weight -0.440 <0.001 -0.492 <0.001 
BMI -0.383 0.002 -0.285 0.24 
PImax -0.345 0.006 -0.335 0.007 
SNIP -0.225 0.077 -0.332 0.008 
FEV1 (actual) -0.365 0.003 -0.449 <0.001 
FEV1 (z score) 0.144 0.261 0.011 0.932 
FVC (actual) -0.424 0.001 -0.577 <0.001 
FVC (z score) 0.101 0.430 -0.013 0.916 
FEV1/FVC ratio (actual) 0.035 0.786 0.198 0.119 
FEV1/FVC ratio (z score) 0.19 0.885 -0.046 0.718 
Table 2  Relationships between EMGpara and EMGpara%max and anthropometry, 
respiratory muscle strength and spirometric parameters 
 
All EMGpara-derived variables were significantly higher in female subjects than 
males (Table 3).  Although the male and female subjects were well matched with 
respect to age (p=0.14) and spirometric parameters expressed relatively to predicted 
(FEV1, FVC and FEV1/FVC ratio z-scores, p>0.2 for all), differences were observed in 
height, weight, BMI, measures of adiposity and respiratory muscle strength between 
men and women (Table 3).  Due to these differences the analyses of relationships 
between EMGpara and anthropometrics, spirometry and respiratory muscle strength 
were repeated within-sex.  Importantly, the relationships observed previously in the 
whole cohort were not retained, suggesting other factors specifically relating to sex 
were the major determinants of EMGpara.   
 
 
Male Female p value 
Height (m) 
177.0 
(174.1 – 182.8) 
164.0 
(161.0 – 167.6) 
<0.001 
Weight (kg) 
78.6 
(71.1 – 90.2) 
60.7 
(52.8 – 65.5) 
<0.001 
BMI (kg.m-2) 
25.5 
(23.0 – 27.2) 
21.7 
(20.1 – 24.7) 
<0.001 
Waist-hip ratio 
0.88 
(0.84 – 0.91) 
0.77 
(0.70 – 0.80) 
<0.001 
Neck circumference 
(cm) 
38.8 
(37.0 – 40.0) 
32.0 
(31.0 – 33.3) 
<0.001 
Fat-free mass (%) 
78.1 
(74.8 – 83.3) 
72.3 
(66.0 – 78.4) 
0.001 
PImax (cmH2O) 
102.2 
(71.0 – 129.3) 
68.9 
(56.9 – 86.8) 
0.001 
SNIP (cmH2O) 
84.3 
(63.3 – 113.6) 
70.8 
(52.5 – 87.9) 
0.39 
EMGpara (µV) 
3.56 
(2.81 – 5.35) 
5.79 
(4.42 – 7.98) 
0.003 
EMGpara%max (%) 
3.80 
(2.56 – 4.69) 
7.66 
(5.24 – 9.92) 
<0.001 
NRDI (%.BPM) 
58.26 
(36.93 – 71.73) 
118.44 
(73.36 – 165.41) 
<0.001 
Table 3  Sex differences in anthropometric variables, respiratory muscle strength and 
measures of NRD 
 
 
Influence of mouthpiece 
EMGpara was significantly higher (4.95 (3.35 – 6.93)µV versus 6.28 (4.26 – 9.93)µV, 
p<0.001), and respiratory rate significantly lower (16 (13 – 18) breaths/minute versus 
13 (11 – 16)breaths/minute, p<0.001) with the mouthpiece in situ.  The change in 
EMGpara when measuring respiratory flow using the mouthpiece, 
pneumtoachograph and nose clip was not, however, significantly related to the 
change in respiratory rate (r=-0.18, p=0.17).  Median (IQR) NRDI was also 
significantly higher with a mouthpiece in situ (73.6 (46.4 – 143.9)%.BPM versus 92.9 
(50.0 – 150.9)%.BPM, p=0.006), suggesting larger tidal volumes with the mouthpiece 
in situ. 
 
 
Predicted values for NRD 
As sex was the primary determinant of EMGpara, reference values for EMGpara 
parameters with and without a mouthpiece in situ for each sex are proposed (Table 
4).  As several data sets demonstrated positive skewness, values for EMGpara 
variables were also log-transformed. 
 
  
  
Males Females 
N
o
 m
o
u
th
p
ie
ce
 
EMGpara (µV) 
4.36 
(3.57 – 5.16) 
6.11 
(5.22 – 6.99) 
EMGpara%max (%) 
3.93 
(3.17 – 4.68) 
7.93 
(6.61 – 9.26) 
NRDI (%.BPM) 
60.95 
(48.60 – 73.30) 
128.23 
(104.29 – 152.17) 
logEMGpara 
1.38 
(1.22 – 1.55) 
1.72 
(1.56 – 1.87) 
logEMGpara%max 
1.26 
(1.07 – 1.44) 
1.95 
(1.76 – 2.13) 
logNRDI 
3.99 
(3.80 – 4.18) 
4.70 
(4.49 – 4.91) 
W
it
h
 m
o
u
th
p
ie
ce
 
EMGpara (µV) 
5.90 
(4.68 – 7.12) 
7.70 
(6.66 – 8.73) 
EMGpara%max (%) 
5.18 
(4.17 – 6.20) 
10.00 
(8.49 – 11.51) 
NRDI (%.BPM) 
64.33 
(50.83 – 77.83) 
146.82 
(118.34 – 175.31) 
logEMGpara 
1.64 
(1.44 – 1.84) 
1.96 
(1.82 – 2.11) 
logEMGpara%max 
1.52 
(1.31 – 1.72) 
2.19 
(2.02 – 2.37) 
logNRDI 
4.00 
(3.76 – 4.24) 
4.83 
(4.62 – 5.04) 
Table 4  Reference values for EMGpara data in male and female subjects.  Data are 
shown as mean (95% CI). 
 
 
 
 
Repeatability of EMGpara 
Intra-occasion repeatability of EMGpara was assessed in 48 subjects (Table 5).  
Although there were no differences in EMGpara%max and maxEMGpara between 
measurements made within the same testing session, EMGpara was significantly 
lower on second measurement (p=0.015).  Bland-Altman analysis demonstrated a 
small bias towards a higher EMGpara (0.63µV), EMGpara%max (0.67%) and 
maxEMGpara (3.05µV) on the first occasion.   
 
The inter-occasion repeatability was also assessed in 19 subjects with a median (IQR) 
of 9 (7 -13) days between occasions (Table 5).  No significant differences were 
observed in any measure and Bland Altman analysis indicated negligible bias 
between occasions for EMGpara (0.21µV), EMGpara%max (0.24%) and maxEMGpara 
(0.81µV). 
 
 First   
measurement 
Second 
measurement 
p value 
In
tr
a-
o
cc
as
io
n
 (
n
=4
8
) EMGpara (µV) 
5.02 
(3.38 – 6.92) 
4.40 
(3.05 – 6.04) 
0.015 
EMGpara%max (%) 
4.92 
(3.67 – 8.12) 
4.71 
(3.41 – 7.15) 
0.14 
maxEMGpara (µV) 
95.36 
(68.54 – 124.60) 
97.24 
(68.04 – 112.38) 
0.712 
In
te
r-
o
cc
as
io
n
 (
n
=1
9
) EMGpara (µV) 
5.20 
(3.45 – 6.91) 
5.17 
(3.48 – 7.28) 
0.546 
EMGpara%max (%) 
4.95 
(3.80 – 8.27) 
6.48 
(4.21 – 7.72) 
1.00 
maxEMGpara (µV) 
95.65 
(66.58 – 127.38) 
77.27 
(63.64 – 136.74) 
0.841 
Table 5  Within- and between-occasion repeat measurements of neural respiratory 
drive in healthy subjects.  Data are shown as median (IQR) 
 
 
To allow comparison of the relative repeatability of the raw versus normalised signal, 
Bland-Altman analyses were also performed expressing values as a percentage of the 
initial measurement.  Wider 95% limits of agreement were noted for both intra- and 
inter-occasion measurements of EMGpara%max compared to EMGpara, although 
there was little difference in the bias values (Table 6).   
 
  Expressed in original 
measurement units 
Expressed as percentage 
of first measurement 
  
Bias 
95% limits of 
agreement 
Bias 
95% limits of 
agreement 
W
it
h
in
-o
cc
as
io
n
 (
n
=
48
) 
EMGpara  0.63 -2.92 – 4.19 10.95 -52.61 – 74.52 
EMGpara%max  0.69 -4.72 – 6.09 8.56 -80.64 – 97.56 
MaxEMGpara 3.05 -78.40 – 84.49 2.18 -56.91 – 61.28 
B
et
w
ee
n
-o
cc
as
io
n
 (
n
=1
9
) 
EMGpara -0.21 -4.42 – 4.00 0.95 -67.88 – 69.77 
EMGpara%max 0.24 -4.81 – 5.29 -1.13 -73.28 – 71.02 
MaxEMGpara 0.81 -39.17 – 40.78 2.12 -36.25 – 40.50 
Table 6  Results of Bland-Altman analyses of repeat measures of EMGpara and 
EMGpara%max 
 
 
 
Discussion 
This is the largest study to date examining factors determining EMGpara levels in 
healthy adult subjects.  The results from this study indicate that sex difference is the 
most important determinant of EMGpara.  A strong influence of anthropometric 
variables was not observed in this cohort.  The results also indicate that normalising 
the raw EMGpara signal to that obtained during a maximal manoeuvre may not 
confer any benefit  with respect to measurement repeatability and that the non-
normalised signal may be of use. 
 
Critique of the method 
Previous studies (Murphy et al., 2011; Reilly et al., 2011; Steier et al., 2011) including 
measurements of EMGpara in healthy individuals have recruited relatively small 
numbers of subjects from staff and students of respiratory physiology departments.  
The high level of understanding and extensive experience in performing respiratory 
function tests means that reference data derived from such cohorts cannot always 
be reliably extrapolated to the wider population.  The substantially larger sample as 
well as the inclusion of naïve subjects suggests that the data from the current study 
will be more relevant when applying EMGpara to patient populations. 
 
While the subjects included in this study were recruited from a variety of 
backgrounds and hence were broadly representative of the wider population, the 
median age was relatively low at 31 years of age.  In addition, many of the older 
subjects studied were masters athletes (Pollock et al., 2015), whose respiratory 
function may not be representative of the wider population of healthy older adults.  
Such factors may have masked any relationship between age and EMGpara, as has 
been demonstrated previously with EMGdi (Jolley et al., 2009).  Studying larger 
numbers of older individuals would help clarify any effects of age.  The 
predominance of Caucasian participants in the current study population prevented 
the influence of ethnicity on EMGpara being examined. 
 
Additional measures to BMI were made to quantify adiposity including bioelectrical 
impedance to assess overall body fat, waist-hip circumference to assess relative 
distribution of fat, and neck circumference as a surrogate marker of upper body 
adiposity.  None of these measures are, however, directly representative of chest 
wall adiposity, which is the main factor associated with attenuation of the EMGpara 
signal.  In addition, the subjects within the current study were predominantly of a 
normal weight, with 20 (31.7%) classified as overweight (BMI>25) and only three 
(4.8%) obese (BMI>30).  In subjects with elevated chest wall adiposity, attenuation of 
the EMGpara signal would be anticipated, but EMGpara%max would be expected to 
remain representative of respiratory load as both the resting and maximal EMGpara 
signals would be filtered to the same extent.  We did not, however, observe any 
significant relationships between EMGpara or EMGpara%max and measures of 
adiposity.  Elevated NRD resulting from the  increases in respiratory load that occurs 
in obesity has been reported previously (Steier et al., 2009).  The presence and/or 
severity of respiratory complications of obesity are not however directly related to 
BMI, and may at least partly depend on the distribution of adipose tissue.  Previous 
data have shown the increased work of breathing and altered lung volumes in 
obesity to be related to waist circumference (Steier et al., 2014).  Equally, the degree 
of EMGpara signal attenuation will not be directly related to body mass, but more 
specifically to the thickness of the upper chest wall fat layer.  The current study was 
not able to quantify muscle-electrode distance directly.  Future studies may benefit 
from using ultrasound to examine the relationship between chest wall skin and fat 
layer thickness and both raw EMGpara and EMGpara%max to determine the degree 
to which obesity both reduces the signal through filtering and results in its elevation 
due to increases in load.  The small variability in such measures in addition to other 
influencing factors does however suggest that a very large sample size would be 
required.  Conducting such large-scale studies with EMGpara is currently challenging 
due to the time consuming nature of manual EMG analysis.  
 
 
 
Significance of the findings 
These data provide limited reference ranges against which patient data from clinical 
studies can be compared and from which sample size calculations for future studies 
can be undertaken.  The results have also highlighted important methodological 
considerations when measuring EMGpara.   
 
Most important of these is the effect of a mouthpiece on neural respiratory drive.  
While the increase in ventilation as a consequence of breathing via a mouthpiece or 
facemask has long been known (Gilbert et al., 1972), the effect of this on EMG based 
indices of NRD has not to our knowledge previously been documented.  Our data 
have quantified the magnitude of this effect.  While ensuring methodological 
consistency within studies is always of utmost importance, the data objectively 
demonstrate that measurements obtained with and without a mouthpiece in situ 
cannot be viewed as interchangeable.  The data also provide reference values for 
EMGpara measurements made both with and without a mouthpiece.  Studies such 
as those involving cardiopulmonary exercise testing may however require the use of 
a facemask and although similar increases in EMGpara may occur, the magnitude of 
this increase should be specifically examined. 
 
Sex differences in NRD during exercise have been previously documented, with 
female subjects shown to have higher EMGdi than males for equivalent minute 
ventilation (Schaeffer et al., 2014).    The increased level of NRD is attributed to sex 
based differences in respiratory system structure, such that after correcting for 
height women have lower lung volumes, narrower airways and lower respiratory 
muscle strength than men (Sheel & Guenette, 2008).  Previous work has also 
indicated a greater ribcage muscle contribution to inspiration in women (Bellemare 
et al., 2003).  The current study adds to these previous findings by demonstrating 
the presence of sex differences in neural respiratory drive at rest.   
 
Between-subject comparison of surface EMG data is known to be confounded by 
differences in muscle-electrode distance, as well as differences in skin composition 
and electrical impedance.  Between-occasion comparisons can also be affected by 
subtle differences in measurement location, despite close attention to standardising 
electrode placement.  Surface EMG measurements are therefore generally 
expressed relative to the EMG signal obtained during a maximal voluntary 
contraction.  The results from the current study have however suggested that such 
an approach may confer little advantage when quantifying EMGpara using the raw, 
non-normalised signal.  Accuracy and consistency of electrode positioning for surface 
EMGpara is facilitated by the use of bony landmarks (positioning the electrode 
midway between the inferior border of the second rib and the superior border of the 
third, and measuring the distance from the sternum) and may therefore be more 
reproducible than surface EMG of large skeletal muscles.  The smaller size of the 
parasternal intercostal muscles results in 19mm diameter surface electrodes 
covering a much larger proportion of the active muscle, making the signal more 
representative of the electrical activation of the whole muscle compared to 
measurements of large skeletal muscles.   
 
The manoeuvres required for normalisation of the EMGpara signal may also result in 
recruitment of accessory inspiratory muscles such as the pectoralis major, located in 
close proximity to the muscle under study.  This can result in substantial cross-talk, 
and acceptance of the maximal EMGpara signal obtained during a contaminated 
effort will result in a falsely low value for EMGpara%max.  Conversely, achieving true 
maximal volitional activation of skeletal muscles can be challenging, even in well-
motivated subjects.  If full activation is not achieved, NRD as quantified by 
EMGpara%max will appear elevated, and subjects may appear to reach supra-
maximal levels of NRD during conditions of heavy load, for example at end-exercise.  
Both of these normalisation errors result in misrepresentation of the respiratory 
load-capacity balance.  In research settings, errors of this nature may preclude 
accurate and useful physiological insights.  When considering clinical application of 
the technique, such errors would be unacceptable due to the potential for 
inappropriate diagnostic or treatment decisions. 
 
We have shown somewhat greater variability of EMGpara%max compared to the 
raw signal alone, with wider limits of agreement for EMGpara%max both within- and 
between-occasion.  These data suggest that use of EMGpara%max may not, 
therefore, confer the advantage with respect to repeatability that has previously 
been assumed.  Using the raw EMGpara signal may allow the technique to be 
applied in more diverse populations, particularly those unable to reliably perform 
the maximal volitionary efforts required for normalisation such as young children or 
sedated patients receiving critical care.  Recent data have demonstrated significantly 
higher raw EMGpara values in preschoolers with wheezing illness and children 
receiving intensive care than healthy youngsters (MacBean et al., 2016).  
 
The limits of agreement between repeat measures are somewhat higher than have 
been reported previously in healthy populations (Murphy et al., 2011; Reilly et al., 
2011).  As stated above, subjects in these earlier studies had experience of 
respiratory measurements and would therefore be expected to produce repeatable 
results.  The use in the current study of an unselected cohort of predominantly naïve 
subjects would more likely represent performance of EMGpara measurements in 
clinical populations.   
 
The limits of agreement from Bland-Altman analyses provide valuable insight as to 
what might be considered a significant change in neural respiratory drive.  If 
considering clinical application of EMGpara-based measurements, however, detailed 
studies of repeatability using patient populations would be required to determine 
thresholds for significant change.  It is likely that the effect of lung and chest wall  
pathology on the respiratory load-capacity balance may be of greater significance 
than the relatively subtle influences affecting NRD in healthy subjects in the current 
study.  Variability of up to 4µV or 5% of maximum represents a much smaller 
proportion of the resting signal in patients with significant lung disease (Murphy et 
al., 2011; Reilly et al., 2011; Steier et al., 2011) compared to the healthy subjects 
studied here.  Of note, however, is the slightly higher within- than between-session 
variability, with higher first measurements within the same testing session.  These 
data suggest that naïve subjects may perhaps require longer to acclimatise prior to 
commencing measurements of neural respiratory drive.  In clinical populations, 
where concerns about diagnosis of or deterioration in a respiratory condition may be 
present, the effect of anxiety may be more notable and therefore have a more 
pronounced effect than that observed in the current study, though as stated above 
the relative contribution of such anxiety over pathophysiological influences may not 
be substantial.   
 
 
Conclusions 
These data provide sex-specific reference values for EMGpara, EMGpara%max  and 
NRDI.  The data from the current study also support the use of the raw EMGpara 
signal to quantify NRD from the parasternal intercostal muscles, expanding the 
potential use of the technique beyond only individuals capable of reliably performing 
maximal inspiratory manoeuvres.  These data substantially advance the potential use 
of surface electromyography of the parasternal intercostal muscles as a marker of 
respiratory load-capacity balance. 
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